Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2006 (2006), Article ID 14869, 4 pages
http://dx.doi.org/10.1155/IDOG/2006/14869
Clinical Study

Symptom Exacerbation and Adherence to Antiretroviral Therapy During the Menstrual Cycle: A Pilot Study

1School of Public Health, University of Texas Health Science Center at Houston, RAS 319, PO Box 20186, Houston, TX 77225, USA
2College of Osteopathic Medicine, Kansas City University of Medicine and Biosciences, Kansas City, MO 64106-1453, USA

Received 15 March 2005; Revised 31 March 2005; Accepted 31 May 2005

Copyright © 2006 Pinaki N. Patel and Richard M. Grimes. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J G Bartlett, “Pocket Guide to Adult HIV/AIDS Treatment,” January 2005. Found at http://hopkins-aids.edu/publications/pocketguide/pocketgd0105.pdf. Last accessed February 16, 2005.
  2. “Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents,” http://hivatis.org, 2004. Last accessed February 16, 2005.
  3. D L Paterson, S Swindells, J Mohr et al., “Adherence to protease inhibitor therapy and outcomes in patients with HIV infection,” Annals of Internal Medicine, vol. 133, no. 1, pp. 21–30, 2000. View at Google Scholar
  4. P Tsasis, “Adherence assessment to highly active antiretroviral therapy,” AIDS Patient Care and STDs, vol. 15, no. 3, pp. 109–115, 2001. View at Publisher · View at Google Scholar
  5. S A Safren, M W Otto, J L Worth et al., “Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring,” Behaviour Research and Therapy, vol. 39, no. 10, pp. 1151–1162, 2001. View at Publisher · View at Google Scholar
  6. A Molassiotis, V Nahas-Lopez, W YR Chung, S WC Lam, C KP Li, and T FJ Lau, “Factors associated with adherence to antiretroviral medication in HIV-infected patients,” International Journal of STD & AIDS, vol. 13, no. 5, pp. 301–310, 2002. View at Google Scholar
  7. A Ammassari, R Murri, P Pezzotti et al., “Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection,” JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 28, no. 5, pp. 445–449, 2001. View at Google Scholar
  8. A A Monforte, A C Lepri, G Rezza et al., “Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients,” AIDS, vol. 14, no. 5, pp. 499–507, 2000. View at Publisher · View at Google Scholar
  9. L M Kuyper, E Wood, J SG Montaner, B Yip, J M O'Connell, and R S Hogg, “Gender differences in HIV-1 RNA rebound attributed to incomplete antiretroviral adherence among HIV-infected patients in a population-based cohort,” JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 37, no. 4, pp. 1470–1476, 2004. View at Publisher · View at Google Scholar
  10. K J Roberts, “Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens,” AIDS Patient Care and STDs, vol. 14, no. 3, pp. 155–168, 2000. View at Publisher · View at Google Scholar
  11. S Cu-Uvin, D J Wright, D Anderson et al., “Hormonal levels among HIV-1-seropositive women compared with high-risk HIV-seronegative women during the menstrual cycle,” Journal of Women's Health & Gender-Based Medicine, vol. 9, no. 8, pp. 857–863, 2000. View at Google Scholar
  12. R L Robinson and R W Swindle, “Premenstrual symptom severity: impact on social functioning and treatment-seeking behaviors,” Journal of Women's Health & Gender-Based Medicine, vol. 9, no. 7, pp. 757–768, 2000. View at Google Scholar
  13. R H Moos, Menstrual Distress Questionnaire Manual, Western Psychological Services, Los Angeles, Calif, 1991.